A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

NCT07296445 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Promyelocytic Leukemia (APL)
Acute Promyelocytic Leukaemia
Acute Promyelocytic Leukemia With PML-RARA
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
APL
Acute Promyelocytic Leukemia
Leukaemia
Leukemia Acute Promyelocytic Leukemia (APL)
Leukemia, Acute

Interventions

DRUG: Oral ATO
DRUG: IV Arsenic Trioxide
DRUG: all-trans retinoic acid (ATRA)

Sponsor

SDK Therapeutics, Inc.